Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients

When a patient receives a kidney transplant, there is a possibility that their body will reject this new organ and a variety of treatments are used to try to prevent this. However, these treatments can cause their own unwanted side effects. In a new Cochrane Review in July 2017, Krishna Karpe and colleagues from Canberra Hospital in Australia looked at the evidence for alleviating this for the group of drugs known as Calcineurin inhibitors. Here ’s Krishna to tell us what they found.
Source: Podcasts from The Cochrane Library - Category: General Medicine Authors: Source Type: podcasts